Treeway
Phase 3Treeway is a clinical-stage biotechnology company founded by two ALS patients, Bernard Muller and Robbert Jan Stuit in 2012. Our mission is to develop therapies for ALS, Alzheimer’s disease and other neurodegenerative diseases.
Founded
2012
Focus
RNA & Gene TherapySmall Molecules
About
Treeway is a clinical-stage biotechnology company founded by two ALS patients, Bernard Muller and Robbert Jan Stuit in 2012. Our mission is to develop therapies for ALS, Alzheimer’s disease and other neurodegenerative diseases.
Company Info
TypePrivate
Founded2012
LocationUtrecht, Netherlands
StagePhase 3
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile